Recall Enforment Report D-0001-2026

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Zydus Pharmaceuticals (USA) Inc, originally initiated on 09-24-2025 for the product Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06. The product was recalled due to failed impurity/degradation specifications:out of specification result for an individual organic impurity. The product was distributed nationwide and the recall is currently ongoing.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0001-202609-24-202510-08-2025Class II912 30-count bottlesEntecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.Failed impurity/degradation specifications:Out of Specification result for an individual organic impurityOngoing
D-0002-202609-24-202510-08-2025Class II600 30-count bottlesEntecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.Failed impurity/degradation specifications:Out of Specification result for an individual organic impurityOngoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
68382-920Entecavir EntecavirTablet, Film CoatedOralZydus Pharmaceuticals Usa Inc.Human Prescription Drug
68382-921Entecavir EntecavirTablet, Film CoatedOralZydus Pharmaceuticals Usa Inc.Human Prescription Drug